Summit Therapeutics Inc.
SMMT
$26.20
$0.190.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -836.84% | -44.72% | -67.37% | -164.50% | -310.31% |
| Total Depreciation and Amortization | 85.00% | -7.41% | -26.67% | -37.50% | -56.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,859.79% | -13.25% | 55.11% | 685.83% | 1,705.14% |
| Change in Net Operating Assets | 614.21% | -247.36% | -108.00% | 114.48% | 122.91% |
| Cash from Operations | -102.24% | -102.99% | -150.13% | -103.38% | -12.74% |
| Capital Expenditure | 100.00% | -10,450.00% | -600.00% | -9.43% | -215.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 175.40% | 707.71% | 37.85% | -3,062.16% | -20,001,700.00% |
| Cash from Investing | 175.37% | 705.75% | 37.83% | -3,015.75% | -96,756.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.89% | 1,482.89% | -87.08% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.89% | 1,482.89% | -477.67% | 89,044.98% | 250,365.00% |
| Foreign Exchange rate Adjustments | 408.33% | 205.56% | -139.71% | 167.06% | -95.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 362.80% | 1,186.78% | -76.72% | 456.60% | -13.88% |